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To understand Staphylococcus aureus nasal carriage and its relationship with subsequent disease, insight into
the natural (nonclinical) bacterial population structure is essential. This study investigated whether the
distributions of S. aureus genotypes that cause colonization differ by geographic locales. High-throughput
amplified fragment length polymorphism (AFLP) analysis was performed on nasal isolates of S. aureus from
healthy American (n  391) and Dutch (n  829) volunteers. In total, 164,970 binary outcomes, covering 135
different markers per isolate, were scored. Methicillin resistance was defined for all strains; pulsed-field gel
electrophoresis typing was performed for the American isolates. The overall population structures of the
American and Dutch S. aureus isolates were comparable. The same four major AFLP clusters (I to IV) and
subclusters were identified for both collections. However, the Dutch methicillin-susceptible S. aureus (MSSA)
isolates were overrepresented in AFLP cluster III (P  0.0016). Furthermore, the majority of the American
methicillin-resistant S. aureus isolates (90.5%) were located in AFLP cluster I (P < 0.0001). This result
identifies differences in the local prevalence of certain S. aureus genotypes. AFLP clusters II and III, which
represent multilocus sequence typing clonal complexes 30 and 45, respectively, account for 46.4% of all MSSA
isolates in the study, suggesting that these two lineages have evolved as extremely successful pandemic
colonizers of humans. In conclusion, the overall population structures of American and Dutch nasal carriage
isolates of S. aureus are surprisingly similar, despite subtle geographic differences in the prevalence of certain
S. aureus genotypes.
Since many Staphylococcus aureus infections occur in per-
sons with prior bacterial colonization of the anterior nares,
knowledge of the human nasal colonization state is of clinical
importance (12). In addition, since some strains of S. aureus
appear to have a higher potential to cause disease than others,
it is essential that studies of nasal carriage include bacterial
strain typing information (6, 12). Studies of S. aureus nasal
carriage have been performed in various geographic regions,
including the United States (3) and The Netherlands (14), and
some of these studies included epidemiological typing of the
bacterial isolates obtained (3, 6). However, whether the distri-
butions of S. aureus genotypes from various geographical lo-
cales differ significantly or are rather similar remains unclear.
We here describe the first high-throughput genotyping effort
for large numbers of nonclinical isolates of S. aureus from
healthy volunteers living in the United States and The Neth-
erlands.
MATERIALS AND METHODS
Bacterial strains. The bacterial strains from the United States that were
included in this study were collected from civilian, noninstitutionalized U.S.
citizens during the National Health and Nutrition Examination Survey in 2001 to
2002. In total, nasal samples from 9,622 persons (1 year old) were obtained as
previously described (3). S. aureus was isolated from 2,964 individuals over the
2-year period. Every 10th methicillin-susceptible S. aureus (MSSA) isolate (n 
307) and all methicillin-resistant S. aureus (MRSA) isolates (n  84) were
included in the study. Nine additional MRSA isolates that were excluded from
the study by Kuehnert et al. (3) were included in the present study (these isolates
were excluded earlier because they were obtained from persons outside the
target cohort). Strain characteristics of the American isolates are presented in
Table 1. Forty-two isolates demonstrated pulsed-field gel electrophoresis
(PFGE) patterns that did not fit within established U.S. lineages (5).
The Dutch strains (n  829) were collected during two different carriage
surveys among children and the elderly. In total, 3,198 children (aged 1 to 19
years) from the city of Rotterdam that participated in a national meningococcal
vaccination campaign (in 2002) were enrolled. S. aureus was isolated from 1,116
of these children (1). All isolates were stored at 80°C in broth containing
glycerol. A random sample of 400 S. aureus carriage isolates was drawn for this
cohort (6). The second collection originated from a community-based prospec-
tive study of the elderly in Rotterdam (2). Nasal swabs were obtained from 3,851
persons over 55 years of age, between 1 April 1997 and 31 December 1999. S.
aureus was isolated from 1,043 elderly persons (9). All isolates were stored at
80°C in glycerol containing broth. A random sample of 429 carriage isolates
was drawn (6). The genotyping data and demographic characteristics for the 829
Dutch strains have been described previously (6). All Dutch isolates were MSSA;
the absence of mecA was confirmed by PCR assay (7). Two S. aureus reference
strains, N315 and Mu50, both of which have been completely sequenced, were
included (4). In total, 1,222 S. aureus strains were typed by amplified fragment
length polymorphism (AFLP).
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AFLP. AFLP analysis was performed on purified DNA (MagNA Pure LC
instrument; Roche Diagnostics, Almere, The Netherlands) from all 1,222 S.
aureus strains as described by Melles et al. (6). We used the predictive
software package Recomb (10) to select optimal enzyme and primer combi-
nations (Keygene N.V., U.S. patent application WO 00/44937). DNA was
digested with MboI and Csp6I, and the linker oligonucleotide pairs for MboI
(5-CTCGTAGACTGCGTACC-3 and 5-GATCGGTACGCAGTCTAC-3)
and Csp6I (5-GACGATGAGTCCTGAC-3 and 5-TAGTCAGGACTCAT-
3) were ligated. Subsequently, nonselective preamplification was performed.
In the final amplification, a labeled MboI primer containing a single selective
nucleotide (either C or G) and a Csp6I primer containing two selective
nucleotides (TA) were used. Amplified material was analyzed using poly-
acrylamide slab gels and autoradiography. Marker fragments were scored and
a binary table of fragment absence (indicated by “0”) or presence (indicated
by “1”) was constructed. AFLP technology is covered by patent applications
owned by Keygene N.V. (2a, 2b).
AFLP data analysis. Analysis of the AFLP data was performed as described
previously (6). The method used for two-dimensional clustering of the data was
agglomerative (successive) hierarchical. This clustering was performed using the
unweighted-pair group method with arithmetic mean, and the similarity metric
was Tanimoto. This defines similarity for binary data (0 and 1) based on the
number of positive attributes that two records have in common. The resulting
dendrogram (Fig. 1) was ordered by average value.
Principle-component analysis (PCA) is a standard multivariate method to
reduce the multidimensional space of the data to its principle component
(PC). The PC computation is displayed as a three-dimensional scatter plot in
which the position along the axes shows the PCA score of the strain. PCA was
used to identify subgroups of AFLP clusters as hidden by a two-dimensional
representation of hierarchical clustering. The distribution of the strains in
four branches was defined on the basis of PCA. Both hierarchical cluster
analysis and PCA were performed using Spotfire DecisionSite 7.2 software.
To compare the distributions of strain categories in different phylogenetic
lineages, Fisher’s exact test was used. A two-sided P value of less than 0.05
was considered significant.
Other laboratory methods. The 391 American S. aureus isolates were
screened for oxacillin resistance by using the Clinical and Laboratory Stan-
dards Institute disk diffusion method as previously described (8). PFGE was
performed for the 391 American S. aureus isolates by using SmaI. The PFGE
patterns were analyzed using BioNumerics (Applied Maths), and isolates
were grouped into PFGE clonal types by using Dice coefficients and a value
of 80% relatedness (3, 5).
RESULTS
Using the set of 1,222 S. aureus isolates, a total of 164,970
binary outcomes were generated, covering 135 scorable AFLP
marker fragments per isolate. The AFLP data for the 829
Dutch isolates, the 391 American isolates, and the two refer-
ence strains (Mu50 and N315) were subjected to two-dimen-
sional hierarchical cluster analysis of which the graphical out-
put is shown in Fig. 1. This figure indicates the presence of the
American isolates and clearly shows that the overall popula-
tion structures of the American and Dutch isolates are rather
comparable: the grouping of the strains into four major AFLP
clusters as defined before for the Dutch isolates remains valid
(Fig. 2) (6). The American isolates do not segregate from the
Dutch isolates, and no additional major S. aureus clones were
identified. Most importantly, strains of homogeneous clusters
II (clonal complex 30 [CC30] by multilocus sequence typing)
and III (CC45) seem to be important “S. aureus carriage lin-
eages” in both The Netherlands and the United States. How-
ever, there are some differences in the distribution of the
Dutch and American isolates across the major AFLP clusters
(Table 2). A greater proportion of isolates of the Dutch col-
lection than of the U.S. collection of strains belonged to AFLP
cluster III (P  0.0016). Additionally, all 829 Dutch strains
were methicillin susceptible, whereas in the original U.S. col-
lection, 75 of 2,964 (2.5%) isolates were resistant to methicillin
(P  0.0001), with a weighted prevalence of MRSA coloniza-
tion among the U.S. population of 0.8% (75 of 9,622) MRSA
isolates in the U.S. cohort (3). Table 2 shows that the majority
of the (American) MRSA isolates (90.5%) are located in
AFLP cluster I, which is a genetically heterogeneous cluster
(overrepresentation of MRSA isolates in cluster I compared to
the other AFLP clusters; P  0.0001). Furthermore, Fig. 3
shows that most MRSA strains in AFLP genetic lineage I are
clustered separately in a small subcluster named Ia (embracing
two PFGE lineages, USA100 and USA800, as shown in Fig. 4).
Subcluster Ia embraces 24 American MSSA isolates (7.8% of
all American MSSA strains included in this study), while it
embraces 60 American MRSA isolates (71.4% of all American
MRSA strains included in this study; P  0.0001).
Figure 4 shows the comparison of AFLP and PFGE typing
of the American S. aureus carriage isolates. PFGE typing con-
firms the genetic homogeneity in AFLP clusters II and III as
well as the relatively high genetic heterogeneity in AFLP clus-
ters I and IV. The different PFGE clonal types (e.g., USA700,
USA900, group A, and group B,) in AFLP cluster I are clus-
tered separately, indicating the similarity between the two typ-
ing methods. Furthermore, as shown in Fig. 4, AFLP analysis
still identifies genetic heterogeneity among several clonal
PFGE types, indicating its high discriminatory power. As de-
scribed earlier, multilocus sequence typing (MLST) analyses of
strains assigned to AFLP clusters I and IV also identified
different clonal lineages (including CC5, CC8, CC15, CC20,
and CC25 in AFLP cluster I and CC22 and CC121 in cluster
IV) (6). In contrast, AFLP clusters II and III are genetically
homogeneous lineages that have previously been corroborated
by MLST and now are confirmed by PFGE analysis. Strains in
AFLP cluster II all belong to CC30 (and PFGE type USA200),
and strains in AFLP cluster III all belong to CC45 (and PFGE
type USA600).
TABLE 1. Microbiological characteristics of the 391 American
S. aureus isolates
PFGE type Total no. (% of total)of isolates
Total no. (% of PFGE type)
of isolates that were:
MSSA MRSA
USA100 46 (11.8) 2 (4.3) 44 (95.7)
USA200 89 (22.8) 88 (98.9) 1 (1.1)
USA300 20 (5.1) 13 (65.0) 7 (35.0)
USA400 6 (1.5) 5 (83.3) 1 (16.7)
USA500 4 (1.0) 3 (75.0) 1 (25.0)
USA600 39 (10.0) 38 (97.4) 1 (2.6)
USA700 13 (3.3) 7 (53.8) 6 (46.1)
USA800 38 (9.7) 21 (55.3) 17 (44.7)
USA900 28 (7.2) 28 (100) 0
USA1000 10 (2.6) 7 (70.0) 3 (30.0)
USA1200 6 (1.5) 6 (100) 0
Group A 18 (4.6) 18 (100) 0
Group B 10 (2.6) 10 (100) 0
Group C 6 (1.5) 6 (100) 0
Group D 11 (2.8) 11 (100) 0
Group E 4 (1.0) 4 (100) 0
Iberian 1 (0.3) 0 1 (100)
Unique 42 (11.0) 40 (93.0) 2 (4.7)
Total 391 (100) 307 (78.3) 84 (21.4)
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DISCUSSION
In the United States, the overall nasal S. aureus colonization
rate among humans was 32.4% (2001 to 2002) (3). This rate is
significantly higher than the prevalence for patients admitted
to Dutch hospitals (24.4%; P  0.0001) (13). Whether this
higher rate is due to the differences between the groups of
volunteers from whom the strains were isolated or to different
sampling methods is unknown. However, despite these differ-
ences in colonization rate and origin of the strains, the popu-
lation structures of American and Dutch isolates are surpris-
ingly similar.
The same major AFLP clusters (I, II, III, and IV) are
identified in both Dutch (n  829) and American (n  391)
community-based nasal isolates of S. aureus. Genetically het-
erogeneous AFLP cluster I was the largest cluster found, com-
prising nearly half of all MSSA isolates and the majority of the
MRSA isolates. However, this cluster could be subdivided in
several subclusters corresponding with different MLST clonal
complexes. Notably, genetically homogeneous AFLP clusters
II and III, which represent MLST clonal complexes 30 and 45,
respectively, account for 46.4% of all carriage MSSA isolates in
the current study population (47.3% of the Dutch carriage
isolates and 44.0% of the American MSSA carriage isolates),
suggesting that these two clonal complexes have evolved to be
extremely successful in colonizing humans (6). It has been
shown before that these two clonal types (CC30 and CC45), as
found in The Netherlands, have a seemingly different potential
to cause invasive infection (11). It would be worthwhile to seek
confirmation of this observation in the American setting. This
confirmation would contribute to our understanding of staph-
ylococcal virulence traits in relation to their clonal back-
grounds. Understanding this relationship may lead to opti-
mized prophylactic and treatment options for the increasing
burden of staphylococcal infections.
FIG. 1. Two-dimensional hierarchical clustering of the 1,222 S. aureus strains. The green/red figure represents 164,970 binary outcomes generated by
high-throughput AFLP with 135 marker fragments per strain. Marker absence corresponds with green, and marker presence corresponds with red (gray
represents ambiguous positions [i.e., weak bands] that are scored as marker absence in the mathematical analyses). The dendrogram on the y axis represents the
phylogenetic clustering of the 1,222 strains. The dendrogram on the x axis shows the clustering of the 135 AFLP markers, many of which segregate in specific
groups. The colored, striped bars on the right represent the distribution of the U.S. strains (blue) and the reference strains Mu50 and N-315 (light green). The
Dutch carriage strains (n  829) are not pointed out separately. In conjunction with PCA, four major branches (I, II, III, and IV) were identified; these are
represented by the black and white bar on the right of the figure. AFLP cluster IVa has been annotated separately (between AFLP cluster I and II), because
these S. aureus strains were assigned (arbitrarily) to cluster IV, based on PCA (Fig. 2 to 4).
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Despite the strong similarity between both S. aureus popu-
lation structures, there are also some differences. Dutch cluster
III strains are overrepresented compared to their American
counterparts (P  0.0016). Furthermore, none of the Dutch
nasal isolates included in the current study carried the mecA
gene. In contrast, the MRSA prevalence in the American col-
lection was approximately 2.5% (P  0.0001) (3). However, it
should be emphasized that methicillin resistance for the Amer-
ican isolates was tested for the total original collection, com-
prising approximately 3,000 S. aureus isolates. Methicillin re-
sistance in the Dutch isolates was tested only for the 829
isolates included in the current study by mecA PCR, as de-
scribed earlier (6). All MRSA strains isolated from the Amer-
ican cohort were included in the current study, in contrast to
the American MSSA isolates, which were selected at random
for the current study (by 1 out of 10). Therefore, we have
compared the Dutch S. aureus isolates with the American
MSSA and MRSA isolates separately. The American MRSA
isolates were clearly overrepresented in major AFLP phy-
FIG. 2. PCA of the AFLP data for all 1,222 S. aureus isolates. The different cubes (plotted in three-dimensional space), colored according to
the source, represent every strain in the study. Each axis represents the score calculated for that strain on each PC. The four circles indicate the
different phylogenetic AFLP clusters. The two reference strains (N315 and Mu50) are not visible, as they are hidden by other strains.
TABLE 2. Distribution of S. aureus strains (n  1220) in the four
phylogenetic branches
AFLP cluster
(clonal complex)
No. of strains (%) per AFLP cluster
Netherlandsa United States(MSSA)
United States
(MRSA) Total
I 367 (44.3) 140 (45.6) 76 (90.5)b 583 (47.8)
II (CC30) 216 (26.1) 95 (30.9) 2 (2.4)c 313 (25.7)
III (CC45) 176 (21.2)d 40 (13.0)d 1 (1.2)e 217 (17.8)
IV 70 (8.4) 32 (10.4) 5 (6.0) 107 (8.8)
Total 829 (100) 307 (100) 84 (100) 1,220 (100)
a All Dutch strains were MSSA.
b Proportionally, more of the MRSA strains in the U.S. cohort than of all the
strains in the Dutch cohort (Fisher’s exact test; P  0.0001) or of the MSSA strains
in the U.S. cohort (Fisher’s exact test; P  0.0001) were distributed into cluster I.
c Proportionally, fewer of the MRSA strains in the U.S. cohort than of all the
strains in the Dutch cohort (Fisher’s exact test; P  0.0001) or of the MSSA strains
in the U.S. cohort (Fisher’s exact test; P  0.0001) were distributed into cluster II.
d Proportionally, more of the carriage strains in the Dutch cohort than of the
MSSA strains in the U.S. cohort (Fisher’s exact test; P 0.0016) were distributed
into cluster III.
e Proportionally, fewer of the MRSA strains in the U.S. cohort than of all the
strains in the Dutch cohort (Fisher’s exact test; P  0.0001) or of the MSSA strains
in the U.S. cohort (Fisher’s exact test; P  0.0005) were distributed into cluster III.
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logenetic lineage I, and additionally, most of them clustered
separately in a subcluster, named Ia. Our data clearly show
that the American MRSA isolates (obtained from the open
population) show significantly less genetic diversity than the
MSSA carriage isolates included in this study, which is in
agreement with the assumption that MRSA strains consist
primarily of a limited number of highly successful pandemic
clones.
PFGE typing showed that the American MSSA and MRSA
isolates in AFLP subcluster Ia are PFGE type USA100 and
USA800 strains. It is known that these clonal PFGE types
share the same MLST sequence type (ST 5) and spa motif
(MDMGMK). Apparently, these PFGE types share the same
genetic background, which is corroborated by MLST and
AFLP analysis. However, McDougal et al. earlier concluded
that the two clonal PFGE types carry different SCCmec
structures and had different susceptibility profiles (5).
USA100 isolates cluster with representatives of the multire-
FIG. 3. Distribution of the American MSSA (n 307) and the American MRSA (n 84) isolates. PCA analysis of the AFLP data for all strains
(n  1,222), showing only the 391 American S. aureus isolates with the distribution of the MSSA versus the MRSA strains.
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sistant New York/Japan clone containing SSCmec II, while
isolates from USA800 cluster with representatives of the
pediatric clone containing SSCmec IV (5). Thus, while these
two lineages have diverged over time, they both appear to
have retained the ability to colonize the nares of humans.
Finally, it should be emphasized that there are several dif-
ferences in the demographics of the two populations surveyed,
which could influence the results of this study. The Dutch S.
aureus isolates were obtained from two separate cohorts, i.e.,
children under 19 years of age and elderly adults over 55 years
of age, and all volunteers were living in the Rotterdam area
(local region in The Netherlands). In contrast, the American S.
aureus isolates were obtained from individuals covering all age
groups and living all over the country.
In conclusion, the population structures of nasal S. aureus
isolates from humans are congruent on both sides of the At-
lantic. The same successful clones are present, although their
relative frequencies may vary with geographic origin. Appar-
ently, both MRSA and MSSA show similar epidemic behavior,
with some clones being notably more successful colonizers of
the human vestibulum nasi.
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